Centiva Capital, LP Cor Medix Inc. Transaction History
Centiva Capital, LP
- $5.76 Billion
- Q2 2025
A detailed history of Centiva Capital, LP transactions in Cor Medix Inc. stock. As of the latest transaction made, Centiva Capital, LP holds 19,683 shares of CRMD stock, worth $226,354. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,683Holding current value
$226,354% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding CRMD
# of Institutions
165Shares Held
29.2MCall Options Held
475KPut Options Held
777K-
Vanguard Group Inc Valley Forge, PA4.33MShares$49.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$40.9 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.58MShares$29.7 Million0.04% of portfolio
-
Paul Singer Elliott Investment Management L.P. | West Palm Beach, Fl2.44MShares$28.1 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA1.6MShares$18.4 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $474M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...